The MoU includes measures such as tighter border controls, capacity building for law enforcement through joint training workshops, scientific collaboration on demand reduction, and expanded programs for prevention, treatment, and rehabilitation.
It also emphasizes stricter monitoring of psychotropic substances and chemical precursors under international oversight to prevent their illicit use.
The agreement was signed during the second meeting of the Iran-Iraq Joint Committee on Counter-Narcotics.
